Many times we hear our patients complain that they are limited because of their diabetes, and they then start to regress, blaming the disease for everything. Would that be worse if you were a top athlete just coming into your prime? And what if your medical team told you that the sport …
Read More »Daily Archives: Jul 11, 2017
Stephen Clancy – Taking Diabetes to the Professional Level
In his fifth year with Team Novo Nordisk, Stephen Clancy is slated to race his second consecutive Tour of Utah. At last year’s race, Stephen said it was an unforgettable experience racing at arguably the toughest race in the United States.
Read More »Jaime Davidson Transcript
Dr. Davidson discusses new diabetes drugs and their impact on patient health, including DKA; new combination drugs; and the expensive side effects of sulfonylureas.
Read More »Dr. Jaime Davidson Full Interview
In this Exclusive Interview, Dr. Davidson discusses his thoughts on new drugs and their impact on patient health, such as DKA.
Read More »A Unifying Pathophysiologic Approach to The Complications of Diabetes in the Context of the Beta-cell Classification of Diabetes Part 2
In this week's Homerun Slides, the phenotypic presentation of the beta-cell.
Read More »International Textbook of Diabetes Mellitus, 4th Ed., Excerpt #81: Insulin Actions In Vivo: Glucose Metabolism Part 8 of 9
Glucose phosphorylation and glucose transport are tightly coupled phenomena. Isoenzymes of HK (HK-I to HK-IV) catalyze the first committed intracellular step of glucose metabolism, the conversion of glucose to G-6-P. HK-I, HK-II, HK-III are single-chain peptides that have a number of properties in common, including a very high affinity for glucose and product inhibition by G-6-P.
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.